Matthew Gall - Chief Financial Officer at iTeos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ITOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Gall since 11/24/2024

Holdings reported by Matthew Gall for iTeos Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $10.21 Aug 29, 2025 Direct
Stock Option (Right to Buy) 0 Aug 29, 2025 Direct Common Stock

Transactions reported by Matthew Gall for iTeos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.